Multaq 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VD9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,031
Award facts
- Contract value 100% obligated
- $10,030.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 15, 2026, for the supply of Multaq 400 mg tablets (60-count packages) with a ceiling value of $10,030.76. This is a firm fixed-price contract with an ultimate completion date of January 16, 2026, and was competitively awarded without any set-aside designation. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026. This prime pharmaceutical contract vehicle enables the company to supply a comprehensive range of medications, vaccines, medical devices, and other critical healthcare commodities to support military healthcare programs globally. Multaq (dronedarone) is an antiarrhythmic medication used for rhythm control in atrial fibrillation patients, reflecting the broad therapeutic scope of products Amerisourcebergen delivers through its federal contracts to military treatment facilities and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7VD9?
SPE2DR26F7VD9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F7VD9 worth?
The government has obligated $10,031 on SPE2DR26F7VD9.
Is contract SPE2DR26F7VD9 an order under another contract?
Yes. SPE2DR26F7VD9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VD9 competed?
The extent of competition for SPE2DR26F7VD9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award